CRYSTALENS ACCOMMODATING IOL AO1UV AO1UV-2100

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2020-03-26 for CRYSTALENS ACCOMMODATING IOL AO1UV AO1UV-2100 manufactured by Bausch + Lomb.

Event Text Entries

[188207914] The intraocular lens (iol) was returned in a plastic specimen cup. The original packaging was not returned, however, the reported lens identification information was written on the label. The lens was in two pieces, as the optic had been cut or torn in half. Three haptic arms were torn off and missing. The fourth haptic arm was bent. Functional testing cannot be performed due to the damage. The cause of the damage cannot be determined. The device history record (dhr) was reviewed and there were no discrepancies or deviations found that related to the reported issue. The lot history, trend analysis, risk analysis and directions for use review are considered acceptable, with the product performing within anticipated rates. The most probable root cause is that this event is patient-related. In the surgeon? S opinion, the most likely cause of the event was asymmetrical posterior capsule contraction causing z-tilt of optic. No corrective action is necessary at this time.
Patient Sequence No: 1, Text Type: N, H10


[188207915] It was reported that approximately six weeks post implant of an intraocular lens (iol) in the left eye (os), that the patient developed z- optic tilt. The patient noticed a decrease in their vision. Iol repositioning / rotation was successfully performed three days post event, but z tilt reoccurred approximately three weeks later. An iol explant and replacement was successfully performed four and half months post original implant using an iol of a different model, but the same diopter. There were no complications with the original surgery. The iol optic was free and clear of any debris. In the physician? S opinion the most likely cause was asymmetrical posterior capsule contraction causing z-tilt of optic. The patient current prognosis is recovering from iol exchange. Patient prognosis is good.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number0001313525-2020-00063
MDR Report Key9885472
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2020-03-26
Date of Report2020-02-26
Date of Event2020-02-25
Report Date2005-01-01
Date Reported to FDA2005-01-01
Date Reported to Mfgr2005-01-10
Date Mfgr Received2020-02-26
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHANIE ANASTASIOU
Manufacturer Street21 NORTH PARK PLACE BLVD
Manufacturer CityCLEARWATER FL 33759
Manufacturer CountryUS
Manufacturer Postal33759
Manufacturer Phone7277246659
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameCRYSTALENS ACCOMMODATING IOL
Generic NameLENS, INTRAOCULAR, ACCOMMODATIVE
Product CodeNAA
Date Received2020-03-26
Returned To Mfg2020-03-25
Model NumberAO1UV
Catalog NumberAO1UV-2100
Lot Number7643510
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Sequence No1
Device Event Key0
ManufacturerBAUSCH + LOMB
Manufacturer Address1400 NORTH GOODMAN STREET ROCHESTER NY 14609 US 14609

Device Sequence Number: 101

Product Code---
Date Received2020-03-26
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.